Cell-type selective phototoxicity achieved with chlorophyll-a derived photosensitizers in a co-culture system of primary human tumor and normal lung cells

Photochemistry and Photobiology

Volumn 87, Issue 6, 2011, Pages 1405-1418

  Tracy, Erin C ^a   Bowman, Mary J ^a   Pandey, Ravindra K ^a   Henderson, Barbara W ^a   Baumann, Heinz ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROPHYLL; CHLOROPHYLL A; PHOTOSENSITIZING AGENT;

ARTICLE; CELL CULTURE; CHEMISTRY; COCULTURE; HUMAN; LUNG TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; CELLS, CULTURED; CHLOROPHYLL; COCULTURE TECHNIQUES; HUMANS; LUNG NEOPLASMS; PHOTOSENSITIZING AGENTS;

EID: 80054980151     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2011.00992.x     Document Type: Article

References (51)

1. Sibata, C. H., V. C. Colussi, N. L. Oleinick, and, T. J. Kinsella, (2001) Photodynamic therapy in oncology. Expert Opin. Pharmacother. 2, 917-927. (Pubitemid 32750348)
2. Henderson, B. W., and, S. O. Gollnick, (2004) Mechanistic principles of photodynamic therapy. In CRC Handbook of Organic Photochemistry and Photobiology. (Edited by, W. Horspool, and, F. Lenci,), pp. 145-1-145-25. CRC Press, Boca Raton, FL, USA.
3. Zheng, X., J. Morgan, S. K. Pandey, Y. Chen, E. Tracy, H. Baumann, J. R. Missert, C. Batt, J. Jackson, D. A. Bellnier, B. W. Henderson, and, R. K. Pandey, (2009) Conjugation of 2-(1′-hexyloxyethyl)-2- devinylpyropheophorbide-a (HPPH) to carbohydrates changes its subcellular distribution and enhances photodynamic activity in vivo. J. Med. Chem. 52, 4306-4318.
4. Svensson, J., A. Johansson, S. Grafe, B. Gitter, T. Trebst, N. Bendsoe, S. Andersson-Engels, and, K. Svanberg, (2007) Tumor selectivity at short times following systemic administration of a liposomal temoporfin formulation in a murine tumor model. Photochem. Photobiol. 83, 1211-1219. (Pubitemid 47438520)
5. Kiesslich, T., B. Krammer, and, K. Plaetzer, (2006) Cellular mechanisms and prospective applications of hypericin in photodynamic therapy. Curr. Med. Chem. 13, 2189-2204. (Pubitemid 44132609)
6. Hahn, S. M., M. E. Putt, J. Metz, D. B. Shin, E. Rickter, C. Menon, D. Smith, E. Glatstein, D. L. Fraker, and, T. M. Busch, (2006) Photofrin uptake in the tumor and normal tissues of patients receiving intraperitoneal photodynamic therapy. Clin. Cancer Res. 12, 5464-5470. (Pubitemid 44497262)
7. Hobbs, S. K., W. L. Monsky, F. Yuan, W. G. Roberts, L. Griffith, V. P. Torchilin, and, R. K. Jain, (1998) Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc. Natl Acad. Sci. USA 95, 4607-4612. (Pubitemid 28207960)
8. Kennedy, J. C., (1993) ALA-PDT: An overview. Photochem. Photobiol. 57S, 76S.
9. Perry, R. R., W. Matthews, J. B. Mitchell, A. Russo, S. Evans, and, H. I. Pass, (1990) Sensitivity of different human lung cancer histologies to photodynamic therapy. Cancer Res. 50, 4272-4276. (Pubitemid 20225663)
10. Schneider, R., L. Tirand, C. Frochot, R. Vanderesse, N. Thomas, J. Gravier, F. Guillemin, and, M. Barberi-Heyob, (2006) Recent improvements in the use of synthetic peptides for a selective photodynamic therapy. Anticancer Agents Med. Chem. 6, 469-488. (Pubitemid 44377781)
11. Gravier, J., R. Schneider, C. Frochot, T. Bastogne, F. Schmitt, J. Didelon, F. Guillemin, and, M. Barberi-Heyob, (2008) Improvement of meta-tetra(hydroxyphenyl)chlorin-like photosensitizer selectivity with folate-based targeted delivery. Synthesis and in vivo delivery studies. J. Med. Chem. 51, 3867-3877. (Pubitemid 351956516)
12. O'Connor, A. E., W. M. Gallagher, and, A. T. Byrne, (2009) Porphyrin and nonporphyrin photosensitizers in oncology: Preclinical and clinical advances in photodynamic therapy. Photochem. Photobiol. 85, 1053-1074.
13. Saussez, S., C. Decaestecker, V. Mahillion, S. Cludts, and, A. Capouillez, (2009) Galectin-3 upregulation during tumor progression in head and neck cancer. Laryngoscope 118, 1583-1590.
14. Nakahara, S, and, A. Raz, (2008) Biological modulation by lectins and their ligands in tumor progression and metastasis. Anticancer Agents Med. Chem. 8, 22-36. (Pubitemid 351445058)
15. Yoshimura, A., A. Gemma, Y. Hosoya, E. Komaki, Y. Hosomi, T. Okano, K. Takenaka, K. Matuda, M. Seike, K. Uematsu, S. Hibino, M. Shibuya, T. Yamada, S. Hirohashi, and, S. Kudoh, (2003) Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer. Genes Chromosomes Cancer 37, 159-164. (Pubitemid 36529783)
16. Robey, R. W., K. Steadman, O. Polgar, and, S. E. Bates, (2005) ABCG2-mediated transport of photosensitizers: Potential impact on photodynamic therapy. Cancer Biol. Ther. 4, 187-194. (Pubitemid 41351317)
17. Liu, W., M. R. Baer, M. J. Bowman, P. Pera, X. Zheng, J. Morgan, R. A. Pandey, and, A. R. Oseroff, (2007) The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2. Clin. Cancer Res. 13, 2463-2470. (Pubitemid 46698598)
18. Morgan, J., J. D. Jackson, X. Zheng, S. K. Pandey, and, R. K. Pandey, (2010) Substrate affinity of photosensitizers derived from chlorophyll-a: The ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy. Mol. Pharm. 7, 1789-1804.
19. Robey, R. W., P. A. Fetsch, O. Polgar, M. Dean, and, S. E. Bates, (2006) The livestock photosensitizer, phytoporphyrin (phylloerythrin), is a substrate of the ATP-binding cassette transporter ABCG2. Res. Vet. Sci. 81, 345-349. (Pubitemid 44296260)
20. Jendzelovsky, R., J. Mikes, J. Koval, K. Soucek, J. Prochazkova, M. Kello, V. Sackova, J. Hofmanova, A. Kozubik, and, P. Fedorocko, (2009) Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells. Photochem. Photobiol. Sci. 8, 1716-1723.
21. Usuda, J., Y. Tsunoda, S. Ichinose, T. Ishizumi, K. Ohtani, S. Maehara, S. Ono, H. Tsutsui, T. Ohira, T. Okunaka, K. Furukawa, Y. Sugimoto, H. Kato, and, N. Ikeda, (2010) Breast cancer resistant protein (BCRP) is a molecular determinant of the outcome of photodynamic therapy (PDT) for centrally located early lung cancer. Lung Cancer 67, 198-204.
22. Mori, H., Y. Yoshida, and, M. Hara, (2011) Neural stem/progenitor cells damaged by reactive oxygen species evolved in photosensitizing reaction. Neurosci. Lett. 493, 24-28.
23. Tamura, A., M. Watanabe, H. Saito, H. Nakagawa, T. Kamachi, I. Okura, and, T. Ishikawa, (2006) Functional validation of the genetic polymorphisms of human ATP-binding cassette (ABC) transporter ABCG2: Identification of alleles that are defective in porphyrin transport. Mol. Pharmacol. 70, 287-296.
24. Srivatsan, A., Y. Wang, P. Joshi, M. Sajjad, Y. Chen, C. Liu, K. Thankppan, J. R. Missert, E. Tracy, J. Morgan, N. Rigual, H. Baumann, and, R. K. Pandey, (2011) In vitro cellular uptake and dimerization of signal transducer and activator of transcription-3 (STAT3) identify the photosensitizing and imaging-potential of isomeric photosensitizers derived from chlorophyll-a and bacteriochlorophyll-a. J. Med. Chem. [Epub ahead of print]
25. Loewen, G. M., E. Tracy, F. Blanchard, D. Tan, J. Yu, S. Raza, S. Matsui, and, H. Baumann, (2005) Transformation of human bronchial epithelial cells alters responsiveness to inflammatory cytokines. BMC Cancer 5, 145.
26. Chattopadhyay, S., E. Tracy, P. Liang, O. Robledo, S. Rose-John, and, H. Baumann, (2007) Interleukin-31 and oncostatin-M mediate distinct signaling reactions and response patterns in lung epithelial cells. J. Biol. Chem. 282, 3014-3026. (Pubitemid 47084348)
27. Liu, W., A. R. Oseroff, and, H. Baumann, (2004) Photodynamic therapy causes cross-linking of signal transducer and activator of transcription proteins and attenuation of interleukin-6 cytokine responsiveness in epithelial cells. Cancer Res. 64, 6579-6587. (Pubitemid 39297917)
28. Henderson, B. W., C. Daroqui, E. Tracy, L. Vaughan, G. M. Loewen, and, M. Cooper, (2007) Cross-linking of signal transducer and activator of transcription 3 (STAT3)-A molecular marker for the photodynamic reaction in cells and tumors. Clin. Cancer Res. 13, 3156-3163. (Pubitemid 46944897)
29. Ozvegy-Laczka, C., T. Hegedus, G. Varady, O. Ujhelly, J. D. Schuetz, A. Varadi, G. Keri, L. Orfi, K. Nemet, and, B. Sarkadi, (2004) High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter. Mol. Pharmacol. 65, 1485-1495. (Pubitemid 38668306)
30. Ishikawa, T., H. Nakagawa, Y. Hagiya, N. Nonoguchi, S. Miyatake, and, T. Kuroiwa, (2010) Key role of human ABC transporter ABCG2 in photodynamic therapy and photodynamic diagnosis. Adv. Pharmacol. Sci. 2010, 587306.
31. Wang, A., Y. Joshi, P Sajjad, M. Chen, Y. Liu, C. Rao, R. Thankppan, J. R. Missert, E. Morgan, J. Rigual, N. Baumann, and, H. Pandey, (2009) Correlation between the cellular-uptake, STAT3 dimerization, in vitro/in vivo photosensitizing efficacy and imaging (PET and fluorescence) potential of multifunctional photosensitizers (isomers) derived from chlorophyll-a and bacteriochlorophyll-a. Cancer Chemother. Pharmacol. 64, 575-583.
32. Mayor, S., and, R. E. Pagano, (2007) Pathways of clathrin-independent endocytosis. Nat. Rev. Mol. Cell Biol. 8, 512-603.
33. Cao, H., J. Chen, M. Awoniyi, J. R. Henley, and, M. A. McNiven, (2007) Dynamin 2 mediates fluid-phase micropinocytosis in epithelial cells. J. Cell Sci. 120, 4167-4177.
34. Berg, P., K. A. Cengel, T. H. Foster, A. W. Girotti, S. O. Gollnick, S. M. Hahn, M. R. Hamblin, A. Kessel, D. Korbelik, M. Moan, J. Mroz, P. Nowis, D. Piette, B. C. Wilson, and, J. Golab, (2011) Photodynamic therapy of cancer: An update. CA Cancer J. Clin. 61, 250-281.
35. Boyle, R. W., and, D. Dophin, (1996) Structure and biodistribution relationships of photodynamic sensitizers. Photochem. Photobiol. 64, 469-485. (Pubitemid 27039801)
36. Krishnamurthy, P., and, J. D. Schuetz, (2006) Role of ABCG2/BCRP in biology and medicine. Annu. Rev. Pharmacol. Toxicol. 46, 381-410. (Pubitemid 43271195)
37. Wu, A., H. Zhang, P. Happel, and, C. Biswal, (2010) Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype. Mol. Cancer Ther. 9, 2365-2376.
38. Lage, F., J. T. Afshari, and, J. Behravan, (2009) Interleukin-1 beta and tumor necrosis factor-alpha increase ABCG2 expression in MCF-7 breast carcinoma cell line and its mitoxantrone-resistant deriative, MCF-7/MX. Inflamm. Res. 58, 669-676.
39. Pradhan, M., L. A. Bembinster, S. C. Baumgarten, and, J. Frasor, (2010) Proinflammatory cytokines enhance estrogen-dependent expression of the multidrug transporter gene ABCG2 through estrogen receptor and NF {kappa} B cooperativity at adjacent response elements. J. Biol. Chem. 285, 31100-31106.
40. Teng, V., and, M. Piquette-Miller, (2007) Regulation of drug transporters during infection and inflammation. Mol. Interv. 7, 99-111. (Pubitemid 46683180)
41. Oleinick, N. L., R. L. Morris, and, I. Belichenko, (2002) The role of apoptosis in response to photodynamic therapy: What, where, why, and how. Photochem. Photobiol. Sci. 1, 1-21. (Pubitemid 37069701)
42. Buytaert, E., M. Dewaele, and, P. Agostinis, (2007) Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim. Biophys. Acta 1776, 86-107. (Pubitemid 47332075)
43. Zhang, M. E., P. Azizuddin, K. Delos Santos, S. M. Chiu, L. Y. Xue, J. C. Berlin, X. Wu, M. Nieminen, M. Kenney, and, N. L. Oleinick, (2009) Structural factors and mechanisms underlying the improved photodynamic cell killing with silicon phthalocyanine photo sensitizers directed to lysosomes versus mitochondria. Photochem. Photobiol. 85, 1189-1200.
44. Murphy, G., (2008) The ADAMs: Signalling scissors in the tumour microenvironment. Nat. Rev. Cancer 8, 929-941.
45. Sorkin, A., and, L. K. Goh, (2009) Endocytosis and intracellular trafficking of ErbBs. Exp. Cell Res. 315, 683-696.
46. Seshadri, M., D. A. Bellnier, L. A. Vaughan, J. A. Spernyak, R. Mazurchuk, T. H. Foster, and, B. W. Henderson, (2008) Light delivery over extended time periods enhances the effectiveness of photodynamic therapy. Clin. Cancer Res. 14, 2796-2805.
47. Rello-Varona, S., J. C. Stockert, M. Canets, P. Acedo, and, A. Villanueva, (2008) Mitotic catastrophe induced in HeLa cells by photodynamic treatment with Zn(II)-phthalocyanine. Int. J. Oncol. 32, 1189-1196.
48. Zenzen, V., and, H. Zankl, (2004) In vitro evaluation of the cytotoxic and mutagenic potential of the 5-aminolevulinic acid hexylester-mediated photodynamic therapy. Mutat. Res. 561, 91-100. (Pubitemid 38845057)
49. Halkiotis, K., D. Yova, and, G. Pantelias, (1999) In vitro evaluation of the genotoxic and clastogenic potential of photodynamic therapy. Mutagenesis 14, 193-198. (Pubitemid 29123784)
50. Chu, T. S., J. S. Chen, J. P. Lopez, F. S. Pardo, J. Aguilera, and, W. M. Ongkeko, (2008) Imatinib-mediated inactivation of Akt regulates ABCG2 function in head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 134, 979-984.
51. Okamoto, A., K. Chikamatsu, K. Sakakura, K. Hatsushika, G. Takahashi, and, K. Masuyama, (2009) Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck. Oral Oncol. 45, 633-639.